390 related articles for article (PubMed ID: 15220189)
1. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting.
Rajala MW; Qi Y; Patel HR; Takahashi N; Banerjee R; Pajvani UB; Sinha MK; Gingerich RL; Scherer PE; Ahima RS
Diabetes; 2004 Jul; 53(7):1671-9. PubMed ID: 15220189
[TBL] [Abstract][Full Text] [Related]
2. Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis.
Asensio C; Cettour-Rose P; Theander-Carrillo C; Rohner-Jeanrenaud F; Muzzin P
Endocrinology; 2004 May; 145(5):2206-13. PubMed ID: 14962997
[TBL] [Abstract][Full Text] [Related]
3. Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia.
Lee JH; Bullen JW; Stoyneva VL; Mantzoros CS
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E625-32. PubMed ID: 15522996
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA.
Makimura H; Mizuno TM; Bergen H; Mobbs CV
Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1266-71. PubMed ID: 12388167
[TBL] [Abstract][Full Text] [Related]
5. Pituitary resistin gene expression: effects of age, gender and obesity.
Morash BA; Ur E; Wiesner G; Roy J; Wilkinson M
Neuroendocrinology; 2004 Mar; 79(3):149-56. PubMed ID: 15103228
[TBL] [Abstract][Full Text] [Related]
6. Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice.
Delporte ML; El Mkadem SA; Quisquater M; Brichard SM
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E446-53. PubMed ID: 15126241
[TBL] [Abstract][Full Text] [Related]
7. Conjugated linoleic acid deteriorates insulin resistance in obese/diabetic mice in association with decreased production of adiponectin and leptin.
Ohashi A; Matsushita Y; Kimura K; Miyashita K; Saito M
J Nutr Sci Vitaminol (Tokyo); 2004 Dec; 50(6):416-21. PubMed ID: 15895517
[TBL] [Abstract][Full Text] [Related]
8. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects.
Heilbronn LK; Rood J; Janderova L; Albu JB; Kelley DE; Ravussin E; Smith SR
J Clin Endocrinol Metab; 2004 Apr; 89(4):1844-8. PubMed ID: 15070954
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and obesity: resistin, a hormone secreted by adipose tissue.
Wolf G
Nutr Rev; 2004 Oct; 62(10):389-94. PubMed ID: 15508908
[TBL] [Abstract][Full Text] [Related]
10. [Resistine--a new hormone secreted by adipose tissue (adipose tissue in insulin resistance)].
Kochan Z; Karbowska J
Przegl Lek; 2003; 60(1):40-2. PubMed ID: 12884646
[TBL] [Abstract][Full Text] [Related]
11. The hormone resistin links obesity to diabetes.
Steppan CM; Bailey ST; Bhat S; Brown EJ; Banerjee RR; Wright CM; Patel HR; Ahima RS; Lazar MA
Nature; 2001 Jan; 409(6818):307-12. PubMed ID: 11201732
[TBL] [Abstract][Full Text] [Related]
12. Low resistin levels in adipose tissues and serum in high-fat fed mice and genetically obese mice: development of an ELISA system for quantification of resistin.
Maebuchi M; Machidori M; Urade R; Ogawa T; Moriyama T
Arch Biochem Biophys; 2003 Aug; 416(2):164-70. PubMed ID: 12893293
[TBL] [Abstract][Full Text] [Related]
13. [Reduced resistin levels in patients with type 2 diabetes mellitus].
Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723
[TBL] [Abstract][Full Text] [Related]
14. Regulation of fasted blood glucose by resistin.
Banerjee RR; Rangwala SM; Shapiro JS; Rich AS; Rhoades B; Qi Y; Wang J; Rajala MW; Pocai A; Scherer PE; Steppan CM; Ahima RS; Obici S; Rossetti L; Lazar MA
Science; 2004 Feb; 303(5661):1195-8. PubMed ID: 14976316
[TBL] [Abstract][Full Text] [Related]
15. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes.
McTernan PG; Fisher FM; Valsamakis G; Chetty R; Harte A; McTernan CL; Clark PM; Smith SA; Barnett AH; Kumar S
J Clin Endocrinol Metab; 2003 Dec; 88(12):6098-106. PubMed ID: 14671216
[TBL] [Abstract][Full Text] [Related]
16. Suppressing hyperinsulinemia prevents obesity but causes rapid onset of diabetes in leptin-deficient
D'souza AM; Johnson JD; Clee SM; Kieffer TJ
Mol Metab; 2016 Nov; 5(11):1103-1112. PubMed ID: 27818936
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic resistin immunoreactivity is reduced by obesity in the mouse: co-localization with alpha-melanostimulating hormone.
Wilkinson M; Wilkinson D; Wiesner G; Morash B; Ur E
Neuroendocrinology; 2005; 81(1):19-30. PubMed ID: 15809509
[TBL] [Abstract][Full Text] [Related]
18. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity.
Watson E; Hahm S; Mizuno TM; Windsor J; Montgomery C; Scherer PE; Mobbs CV; Salton SR
Endocrinology; 2005 Dec; 146(12):5151-63. PubMed ID: 16141392
[TBL] [Abstract][Full Text] [Related]
19. Resistin/ADSF/FIZZ3 in obesity and diabetes.
Sul HS
Trends Endocrinol Metab; 2004 Aug; 15(6):247-9. PubMed ID: 15358276
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice.
Asakawa A; Inui A; Kaga T; Katsuura G; Fujimiya M; Fujino MA; Kasuga M
Gut; 2003 Jul; 52(7):947-52. PubMed ID: 12801949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
